Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 226

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Postmenopausal Hypertension: Mechanisms and Therapy

Barton, Matthias, Meyer, Matthias R. · 2009 · Hypertension

Abstract

ypertension in women is often undiagnosed or inade- quately treated, especially after menopause when cardiovascular risk increases.In premenopausal women, endogenous estrogens maintain vasodilation and thus contribute to blood pressure control.Aging and the loss of endogenous estrogen production after menopause are accompanied by increases in blood pressure, contributing to the high prevalence of hypertension in older women.Currently, Ϸ75% of postmenopausal women in the United States are hypertensive.The high prevalence of obesity, the lack of regular physical exercise, and dietary salt are important factors contributing to and aggravating postmenopausal hypertension.In view of the ongoing population aging throughout the world, diagnosis and treatment of hypertension in postmenopausal women are important to reduce the excess burden of associated cardiovascular disease and to improve outcomes of potentially fatal complications such as stroke and myocardial infarction.This article discusses current knowledge about the mechanisms and therapeutic issues related to postmenopausal hypertension. Hypertension: Important Determinant of Cardiovascular Risk in WomenMore than 25% of the female adult world population is hypertensive. 1Elevations in blood pressure in women are related to cardiovascular risk (Figure, panel A), 2,3 with the prevalence of hypertension being particularly high among women aged Ն60 years. 1 In the United States, Ϸ75% of postmenopausal women are hypertensive. 4Hypertension is often accompanied by other cardiovascular risk factors, eg, obesity, dyslipidemia, and diabetes mellitus. 5It is noteworthy that the prevalence of hypertension-related cardiovascular complications is greater in postmenopausal women than in age-matched men. 6Indeed, these complications represent the leading cause of death in women. 6linical studies have documented beneficial effects of antihypertensive therapy on cardiovascular outcome, 5 even in patients Ն80 years of age. 7Overall recognition, control, and treatment of hypertension in postmenopausal women are still poor in primary care, and hypertension is often not being treated aggressively enough. 4,8 -10Thus, further improve-ments of medical and public health measures, awareness of patients and physicians, and improved information policies are needed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/hypertensionaha.108.120022

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Research works printed but not linked: 74

  1. 10.1016/S0140-6736(05)70151-3 · DOI · Paper page
  2. 10.1056/NEJMoa003417 · DOI · Paper page
  3. 10.1016/S0140-6736(02)11911-8 · DOI · Paper page
  4. 10.1161/hyp.36.5.780 · doi:10.1161/hyp.36.5.780
  5. 10.1161/hypertensionaha.107.107086 · DOI
  6. 10.1016/S0008-6363(01)00527-2 · DOI · Paper page
  7. 10.1161/01.hyp.0000223064.62762.0b · DOI · Paper page
  8. 10.1097/00004872-200211000-00002 · DOI
  9. 10.1161/01.hyp.8.11.1044 · DOI · Paper page
  10. 10.1016/j.maturitas.2004.01.010 · DOI
  11. 10.1161/hypertensionaha.107.105742 · DOI · Paper page
  12. Staessen J, Bulpitt CJ, Fagard R, Lijnen P, Amery A. The influence of menopause on blood pressure. J Hum Hypertens. 1989; 3: 427–433.
  13. 10.1016/S0378-5122(99)00089-4 · DOI
  14. 10.1016/j.amjhyper.2007.04.019 · DOI
  15. 10.1210/jc.2007-0425 · DOI · Paper page
  16. 10.1016/S0378-5122(03)00252-4 · DOI
  17. 10.1161/ATVBAHA.106.130260 · DOI
  18. 10.1161/01.hyp.0000151825.36598.36 · DOI · Paper page
  19. 10.1007/s11906-006-0080-1 · DOI · Paper page
  20. 10.1016/j.genm.2008.03.005 · doi:10.1016/j.genm.2008.03.005
  21. 10.1007/s100380070002 · DOI
  22. 10.1097/01.hjh.0000188728.66183.92 · DOI
  23. 10.1146/annurev.physiol.70.113006.100518 · DOI · Paper page
  24. 10.1161/hypertensionaha.107.089995 · DOI · Paper page
  25. 10.1016/j.genm.2008.03.004 · DOI
  26. 10.1016/j.amjhyper.2004.08.009 · DOI · Paper page
  27. 10.1093/ndt/13.6.1430 · DOI
  28. 10.1161/hyp.37.2.645 · doi:10.1161/hyp.37.2.645
  29. 10.1016/S0002-9440(10)63929-6 · DOI
  30. 10.1159/000092984 · DOI
  31. 10.3109/10641968309048813 · DOI
  32. 10.1161/hyp.27.3.481 · doi:10.1161/hyp.27.3.481
  33. 10.1016/0895-7061(95)00268-5 · DOI
  34. 10.1016/S0895-7061(97)00226-4 · DOI
  35. 10.1016/S0140-6736(97)05189-1 · DOI · Paper page
  36. 10.1161/01.hyp.0000245138.09687.8a · DOI
  37. 10.1161/01.hyp.0000218857.67880.75 · DOI
  38. 10.1097/00004872-200312000-00031 · doi:10.1097/00004872-200312000-00031
  39. 10.1097/01.ASN.0000128219.65330.EA · DOI · Paper page
  40. 10.1016/j.genm.2008.05.002 · doi:10.1016/j.genm.2008.05.002
  41. 10.1097/GME.0b013e31803c764d · DOI · Paper page
  42. 10.1124/jpet.103.058057 · DOI
  43. 10.1210/jc.2005-2339 · DOI
  44. 10.1158/1078-0432.CCR-04-1789 · DOI
  45. 10.7326/0003-4819-121-12-199412150-00005 · DOI · Paper page
  46. 10.1016/S0378-5122(99)00051-1 · doi:10.1016/s0378-5122(99)00051-1
  47. 10.1210/jcem.84.6.5724 · DOI · Paper page
  48. 10.1378/chest.127.5.1498 · DOI
  49. 10.1016/j.cardiores.2004.12.012 · DOI · Paper page
  50. 10.1016/j.atherosclerosis.2005.03.043 · DOI · Paper page
  51. 10.1056/NEJM200201033460114 · DOI
  52. Collins P, Flather M, Lees B, Mister R, Proudler AJ, Stevenson JC, for the WHISP (Women’s Hormone Intervention Secondary Prevention Study) Pilot Study Investigators. Randomized trial of effects of continuous combined HRT on markers of lipids and coagulation in women with acute coronary syndromes: WHISP Pilot Study. Eur Heart J. 2006; 27: 1046–1053.
  53. 10.1055/s-0037-1616085 · DOI
  54. 10.1016/j.amjhyper.2005.10.006 · DOI
  55. 10.1016/S0029-7844(97)84258-5 · DOI
  56. 10.1161/circ.103.24.2903 · doi:10.1161/circ.103.24.2903
  57. 10.1038/nm0397-324 · DOI · Paper page
  58. 10.1161/hypertensionaha.107.106575 · DOI
  59. 10.1161/circ.94.3.483 · doi:10.1161/circ.94.3.483
  60. 10.1021/ja01645a010 · DOI · Paper page
  61. 10.1161/hyp.29.4.976 · doi:10.1161/hyp.29.4.976
  62. 10.1093/eurheartj/ehm296 · DOI · Paper page
  63. Preston RA Effects of blood pressure reduction on cardiovascular risk estimates in hypertensive postmenopausal women. Climacteric. 2007; 10 (suppl 1): 32–41.
  64. 10.1016/j.amjcard.2004.07.153 · DOI
  65. 10.1097/00004872-199312000-00011 · DOI
  66. 10.1161/hypertensionaha.108.110478 · DOI
  67. 10.1080/gye.15.5.397.405 · DOI
  68. 10.1097/gme.0b013e318150d13e · DOI
  69. Meyer MR Haas E Prossnitz ER Barton M. Non-genomic regulation of vascular cell function and growth by estrogen. Mol Cell Endocrinol. In press.
  70. Prossnitz ER Barton M. Signaling physiological functions and clinical relevance of the G-protein-coupled estrogen receptor GPER. Prostaglandis Other Lipid Mediat. In press.
  71. Lindsey SH Cohen JA Brosnihan KB Gallagher PE Chappell MC. Chronic treatment with the GPR30 agonist G-1 decreases blood pressure in ovariectomized mREN2 Lewis rats. Endocrinology. In press.
  72. 10.1161/01.hyp.0000032940.33466.12 · DOI · Paper page
  73. 10.1161/hypertensionaha.107.099234 · DOI
  74. 10.1161/hypertensionaha.108.128033 · doi:10.1161/hypertensionaha.108.128033

Cited by

See all 226

Metadata

Authors
Barton, M., & Meyer, M. R.
Venue
Hypertension
Published
2009-07
Volume
54
Issue
1
Pages
11-18
ISSN
  • 0194-911X (ISSN-L)
  • 1524-4563
OpenAlex
W2076013115
Cited by
226
References
16
FWCI
7.61
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Postmenopausal Hypertension: Mechanisms and Therapy. https://app.cochat.ai/papers/10.1161/hypertensionaha.108.120022
The paper
Barton, M., & Meyer, M. R. (2009). Postmenopausal Hypertension: Mechanisms and Therapy. Hypertension. https://doi.org/10.1161/hypertensionaha.108.120022

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.